Search clinical trials for: Extended Spectrum Beta-Lactamase (ESBL)

Total 9808 results

University Hospital, Angers

Unknown

Factors Influencing the Fecal Relative Abundance of ESBL-producing Enterobacteriaceae in Intensive Care (BLSE-REA).

ESBL-producing Enterobacteriaceae Infections
University Hospital, Clermont-Ferrand
University Hospital, Estaing; Hopital Gabriel Montpied

Unknown

Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff (REASSE)

Antibiotic Resistance | Extended-spectrum Betalactamase | Enterobacteriaceae | Escherichia Coli

France
University of Bordeaux

Unknown

Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection (Microbe)

Critical Illness | Microbial Colonization | Extended Spectrum Beta-Lactamase Producing Bacteria Infection

France
University Hospital, Basel, Switzerland

Recruiting

Transmission of ESBL-producing Enterobacteriaceae

Hospital Acquired Infection

Switzerland
University Hospital, Geneva

Unknown

The Burden and Genetic Variability of Extended-Spectrum ß-Lactamase (ESBL) - Producing Pathogens in Swiss Children

Enterobacteriaceae Infections

Switzerland
Centre Hospitalier Universitaire de Besancon
University Hospital, Geneva; UMC Utrecht; University of Oxford; University Hospital... and other collaborators

Completed

Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities (MODERN)

Enterobacteriaceae Infections | Resistance Bacterial

France
University Hospital, Geneva

Completed

Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study

Enterobacteriaceae Infections

Switzerland
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)

Bacterial Infection
Vestre Viken Hospital Trust
University of Oslo; University Hospital of North Norway; Helse Sor-Ost

Completed

Extended Spectrum Betalactamase Producing Bacteria; Epidemiology and Treatment in Non-hospitalized Patients (ESCAPE)

Urinary Tract Infection | Infection Due to ESBL Bacteria | Environmental Contamination of ESBL
José Raimundo Araujo de Azevedo

Not yet recruiting

Resistance Profile of Escherichia Coli in Infections of Community Origin: The Importance of Antimicrobial Stewardship

Antimicrobial Resistance
University of Pittsburgh

Completed

Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms

Enterobacteriaceae Infections

United States
Duke University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli (SHREC)

E Coli Infection

United States
Belpharma s.a.

Withdrawn

Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae (TEA)

Urinary Tract Infection

United Kingdom
Assistance Publique - Hôpitaux de Paris

Terminated

Deescalating Carbapenems in Hospital Setting (CARBEPARGNE)

Urinary Infection | Digestive Infection | Biliary Infection | Expanded-spectrum Beta-lactamase Producing ESBL
University of Pittsburgh

Completed

Community - Associated Extended-spectrum Beta-lactamases (ESBL)

Infection | Proteus Infections | Klebsiella Infections | E Coli Infections

United States
Beneficência Portuguesa de São Paulo
Merck Sharp & Dohme LLC

Not yet recruiting

Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens (CLEMENT)

Febrile Neutropenia

Brazil
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli

Infection

Taiwan
Maria J.G.T. Vehreschild

Terminated

Controling Intestinal Colonization With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae ESBL-E (CLEAR)

Cancer

Germany
University Hospital, Basel, Switzerland
Stiftung Forschung Infektionskrankheiten, Basel, Switzerland

Completed

Simplified GBS Screening and Prevalence of ESBL in Pregnant Women

Group B Streptococcal Infection | Infection Due to ESBL Bacteria

Switzerland
Jian-cang Zhou M.D.

Completed

Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis

Community Acquired Infection

China
Inje University

Completed

The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

End-stage Renal Disease

Korea, Republic of
Assistance Publique - Hôpitaux de Paris

Completed

Temocillin in ESBL-Enterobacteriaceae Infections (TMO2016)

Infectious Disease

France
University Hospital, Akershus
Oslo University Hospital; Helse Stavanger HF; Sorlandet Hospital HF; Sykehuset... and other collaborators

Terminated

Fecal ESBL Resurgence During Antibiotic Treatment

Antibiotic Drug Resistance
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of Antibiotic Utilization Measures and Control of ESBLs in China

ICU Patient
University of Siena
Merck Sharp & Dohme LLC

Unknown

Infections Caused by ESbL-Producing Enterobacteriaceae in Italy

Skin Diseases | Pneumonia | Bacteremia | Urinary Tract Infections | Enterobacteriaceae Infections

Italy
American University of Beirut Medical Center
Merck Sharp & Dohme LLC

Completed

Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms

Escherichia Coli Infections | Klebsiella Pneumonia

Lebanon
Military Institute of Medicine, Poland

Unknown

"Peri-operative Antimicrobial Prophylaxis in Patients With Asymptomatic Bacteriuria of Enterobacteriacae ESBL+ Origin" (ESBL)

Asymptomatic Bacteriuria | Antimicrobial Prophylaxis

Poland
University of Latvia
Latvian Biomedical Research and Study Centre

Enrolling by invitation

Effects of H.Pylori Eradication on Microbiome

Human Microbiome

Latvia
Institut de Médecine et d'Epidémiologie Appliquée...
ANRS, Emerging Infectious Diseases

Unknown

Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs (BMR-IST)

HIV Infections | Bacterial Infections

France
Mahidol University

Unknown

Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli

Infections

Thailand
University of Tartu
Estonian University of Life Sciences

Unknown

Epidemiology of Resistant Microbial Strains Among Different Groups of People (Healthy, Infected and Exposed to Animals) (ABRESIST)

Methicillin Resistant Staphylococcus Aureus (MRSA) | Vancomycin (Glycopeptide) Resistant Enterococcus (VRE) | ESBL Producing E.Coli | ESBL Producing K.Pneumoniae | Multidrug Resistant P.Aeruginosa | Carbapenem Resistant P.Aeruginosa
University Hospital, Basel, Switzerland
Gebert Rüf-Stiftung

Active, not recruiting

Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

Extended Spectrum Beta Lactamases (ESBL) E. Coli

Switzerland
Tan Tock Seng Hospital
Mayo Clinic

Unknown

Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT) (RABbIT)

Sepsis | Fungemia | Bacteremia | Blood Stream Infection

Singapore
University of Pittsburgh

Completed

Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species

Infection | ESBL | Quinolone Resistance | Klebsiella Species

United States
Nantes University Hospital

Completed

Prevalence of ESBL and CPE in French Nursing Homes (CARBEHPAD)

Enterobacteriaceae Infections

France
Centre Hospitalier Universitaire de Besancon

Completed

Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes. (R'EHPAD)

Drug Resistance, Bacterial

France
University Hospital, Grenoble
French National Network of Clinical Research in Infectious Diseases (RENARCI)

Unknown

Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae (TEMO-ESBL)

Urinary Tract Infections

France
Fondation Hôpital Saint-Joseph

Recruiting

Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient? (COPROBLSE2)

Enterobacteria Infections

France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care

Klebsiella Infections | Escherichia Coli Infections

Korea, Republic of
Haydom Lutheran Hospital
University of Bergen; Helse Stavanger HF; Muhimbili University of Health and... and other collaborators

Active, not recruiting

Use of Probiotics to Reduce Infections, Death and ESBL Colonisation (ProRIDE)

Neonatal Sepsis

Tanzania
University of Pittsburgh

Completed

Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli

Enterobacteriaceae Infections

United States
Lund University

Completed

Can Probiotic Vivomixx Eradicate Colonization With ESBL?

Antibiotic Resistant Infection

Sweden
The Interregional Association for Clinical Microbiology...

Completed

In Vitro Activity of Ceftolozane-tazobactam Against Contemporary Nosocomial Gram "-" Pathogens Isolated in Russia

Nosocomial Infection

Russian Federation
Pfizer

Completed

Assessing Prevalence Of Beta Lactamase Production From Clinical Isolates Of Hospitalized Patients And Comparison Of Antibiotic Susceptibility Patterns (EGAST 2008)

Infection

India
Tel-Aviv Sourasky Medical Center

Unknown

Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers (MOSAR)

Methicillin-Resistant Staphylococcus Aureus | ESBL

Israel
Fundación Pública Andaluza para la gestión de la...
Spanish Network for Research in Infectious Diseases

Completed

Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli (FOREST)

Infection Due to ESBL Escherichia Coli

Spain
Tel-Aviv Sourasky Medical Center

Unknown

Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community (MOSAR)

Methicillin-Resistant Staphylococcus Aureus | ESBL Infection

Israel
Catholic University of the Sacred Heart
University Hospital, Geneva; Universiteit Antwerpen; Clinical Centre of Serbia; Canisius-Wilhelmina Hospital and other collaborators

Unknown

SATURN 04 Nosocomial Acquisition Study (SATURN)

Infection Due to ESBL Bacteria | Bacterial Resistance | Infection Resistant to Multiple Drugs | Staph Aureus Methicillin Resistant Colonization

Italy, Romania, Serbia
Assistance Publique - Hôpitaux de Paris
Direction Générale de l'Offre de Soins

Completed

Digestive Colonisation by Highly Resistant Bacteria (CODBAHRE) (CODBAHRE)

Risk Factor

France
Universidad Autonoma de Nuevo Leon
Hospital Universitario Dr. Jose E. Gonzalez

Completed

Urinary Tract Infections Caused by ESBL-producing Enterobacteria

Urinary Tract Infections

Search clinical trials for: Extended Spectrum Beta-Lactamase (ESBL)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations